BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, He W. Biological drug and drug delivery-mediated immunotherapy. Acta Pharm Sin B 2021;11:941-60. [PMID: 33996408 DOI: 10.1016/j.apsb.2020.12.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Zhang M, Li X, Li G, Yang B, Lu X, Gao Y, Sun F. Nano-Based Co-Delivery System for Treatment of Rheumatoid Arthritis. Molecules 2022;27:5973. [DOI: 10.3390/molecules27185973] [Reference Citation Analysis]
2 Liu X, Sun S, Wang N, Kang R, Xie L, Liu X. Therapeutic application of hydrogels for bone-related diseases. Front Bioeng Biotechnol 2022;10:998988. [DOI: 10.3389/fbioe.2022.998988] [Reference Citation Analysis]
3 Liu Y, Lu T, Liu Z, Ning W, Li S, Chen Y, Ge X, Guo C, Zheng Y, Wei X, Wang H. Six macrophage-associated genes in synovium constitute a novel diagnostic signature for osteoarthritis. Front Immunol 2022;13:936606. [DOI: 10.3389/fimmu.2022.936606] [Reference Citation Analysis]
4 Li H, Wu X, Bu D, Wang L, Xu X, Wang Y, Liu Y, Zhu P. Recombinant jurkat cells (HMGN2-T cells) secrete cytokines and inhibit the growth of tumor cells. J Mol Histol 2022. [PMID: 35861945 DOI: 10.1007/s10735-022-10084-8] [Reference Citation Analysis]
5 Xiao Q, Li X, Liu C, Jiang Y, He Y, Zhang W, Azevedo HS, Wu W, Xia Y, He W. Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.012] [Reference Citation Analysis]
6 Ma S, Zhang J, Liu H, Li S, Wang Q. The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease. Front Cell Dev Biol 2022;10:896591. [PMID: 35721513 DOI: 10.3389/fcell.2022.896591] [Reference Citation Analysis]
7 Ye Z, Wang XK, Lv YH, Wang X, Cui YC. The Integrated Analysis Identifies Three Critical Genes as Novel Diagnostic Biomarkers Involved in Immune Infiltration in Atherosclerosis. Front Immunol 2022;13:905921. [PMID: 35663954 DOI: 10.3389/fimmu.2022.905921] [Reference Citation Analysis]
8 Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. Adv Sci (Weinh) 2022;:e2201734. [PMID: 35652198 DOI: 10.1002/advs.202201734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wang R, Yuan T, Wang J, Chen Y, Zhao J, Li M, Fang L, Du G. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective. Pharmacological Research 2022;180:106238. [DOI: 10.1016/j.phrs.2022.106238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Lee SH, Song JG, Han H. Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite system. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.06.006] [Reference Citation Analysis]
11 Lu T, Liu Z, Guo D, Ma C, Duan L, He Y, Jia R, Guo C, Xing Z, Liu Y, Li T, He Y. Transcriptome-Based Dissection of Intracranial Aneurysms Unveils an “Immuno-Thermal” Microenvironment and Defines a Pathological Feature-Derived Gene Signature for Risk Estimation. Front Immunol 2022;13:878195. [DOI: 10.3389/fimmu.2022.878195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li KX, Wang ZC, Machuki JO, Li MZ, Wu YJ, Niu MK, Yu KY, Lu QB, Sun HJ. Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension? Front Physiol 2022;13:848867. [PMID: 35530510 DOI: 10.3389/fphys.2022.848867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li X, Gu J, Xiao Q, Liu Y, Zhou P, Fan L, Zhang X, Lu X, Wu J, Liu Z, He W. Liposomal codelivery of inflammation inhibitor and collagen protector to the plaque for effective anti-atherosclerosis. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.04.081] [Reference Citation Analysis]
14 Kavasi R, Neagu M, Constantin C, Munteanu A, Surcel M, Tsatsakis A, Tzanakakis GN, Nikitovic D. Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas. Front Med 2022;9:879500. [DOI: 10.3389/fmed.2022.879500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Reference Citation Analysis]
16 Liu Y, Lu Y, Ning B, Su X, Yang B, Dong H, Yin B, Pang Z, Shen S. Intravenous Delivery of Living Listeria monocytogenes Elicits Gasdmermin-Dependent Tumor Pyroptosis and Motivates Anti-Tumor Immune Response. ACS Nano 2022;16:4102-15. [PMID: 35262333 DOI: 10.1021/acsnano.1c09818] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Wu C, Zhang J, Wang K, Fan M, Hu Y. FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991. Evid Based Complement Alternat Med 2022;2022:3945446. [PMID: 35280504 DOI: 10.1155/2022/3945446] [Reference Citation Analysis]
18 Czaja AJ. Advancing Biologic Therapy for Refractory Autoimmune Hepatitis. Dig Dis Sci 2022. [PMID: 35147819 DOI: 10.1007/s10620-021-07378-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Thapa Magar K, Boafo GF, Li X, Chen Z, He W. Liposome-based delivery of biological drugs. Chinese Chemical Letters 2022;33:587-96. [DOI: 10.1016/j.cclet.2021.08.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
20 Zoulikha M, Xiao Q, Boafo GF, Sallam MA, Chen Z, He W. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Acta Pharm Sin B 2022;12:600-20. [PMID: 34401226 DOI: 10.1016/j.apsb.2021.08.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 15.0] [Reference Citation Analysis]
21 Murray EJ, Gumusoglu SB, Santillan DA, Santillan MK. Manipulating CD4+ T Cell Pathways to Prevent Preeclampsia. Front Bioeng Biotechnol 2022;9:811417. [DOI: 10.3389/fbioe.2021.811417] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Qin L, Zheng Q, Liu J, Zhou X, Wang Y, Zhang M. Structural regulation of Co-based coordination polymers by adjusting solvent polarity toward electrocatalytic hydrogen evolution performance. New J Chem 2022;46:7355-65. [DOI: 10.1039/d2nj00945e] [Reference Citation Analysis]
23 Hu X, Zhao P, Lu Y, Liu Y. ROS-Based Nanoparticles for Atherosclerosis Treatment. Materials (Basel) 2021;14:6921. [PMID: 34832328 DOI: 10.3390/ma14226921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Du X, Hou Y, Huang J, Pang Y, Ruan C, Wu W, Xu C, Zhang H, Yin L, He W. Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response. Acta Pharm Sin B 2021;11:3272-85. [PMID: 34729315 DOI: 10.1016/j.apsb.2021.03.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 Hong S, Ju S, Yoo JW, Ha NC, Jung Y. Design and evaluation of IKK-activated GSK3β inhibitory peptide as an inflammation-responsive anti-colitic therapeutic. Biomater Sci 2021;9:6584-96. [PMID: 34582526 DOI: 10.1039/d1bm00533b] [Reference Citation Analysis]
26 Zhang Q, Zhang W, Liu J, Yang H, Hu Y, Zhang M, Bai T, Chang F. Lysophosphatidylcholine promotes intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells via an orphan G protein receptor 2-mediated signaling pathway. Bioengineered 2021;12:4520-35. [PMID: 34346841 DOI: 10.1080/21655979.2021.1956671] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Wu W, Li T, Zheng Y. Editorial of Special Issue "The Biological Fate of Drug Nanocarriers". Acta Pharm Sin B 2021;11:850-1. [PMID: 33996403 DOI: 10.1016/j.apsb.2021.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, Chen Z. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. Int J Pharm 2021;600:120461. [PMID: 33711470 DOI: 10.1016/j.ijpharm.2021.120461] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]